New eye injection shows promise for rare vision loss diseases
NCT ID NCT05282953
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 28 times
Summary
This study tested a new drug called KIO-301, given as an injection into the eye, for people with two rare eye diseases that cause vision loss: retinitis pigmentosa and choroideremia. The goal was to check if the drug is safe and if it can help improve vision. The study included 32 adults aged 18 to 80 and looked at side effects and changes in eye health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harley Eye Clinic
North Adelaide, South Australia, 5006, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Save Sight Institute
Sydney, New South Wales, 2001, Australia
Conditions
Explore the condition pages connected to this study.